Cormorant Asset Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,250,000
| Closed | -$29.4M | – | 67 |
|
|
2024
Q1 | $29.4M | Hold |
3,250,000
| – | – | 1.29% | 25 |
|
|
2023
Q4 | $35.3M | Buy |
3,250,000
+625,000
| +24% | +$6.79M | 1.69% | 17 |
|
|
2023
Q3 | $21.1M | Buy |
+2,625,000
| New | +$21.1M | 1.23% | 23 |
|
|
2018
Q4 | – | Sell |
-75,000
| Closed | -$3M | – | 69 |
|
|
2018
Q3 | $3M | Sell |
75,000
-44,528
| -37% | -$1.78M | 0.2% | 53 |
|
|
2018
Q2 | $3.38M | Hold |
119,528
| – | – | 0.25% | 51 |
|
|
2018
Q1 | $1.83M | Sell |
119,528
-5,472
| -4% | -$83.6K | 0.14% | 46 |
|
|
2017
Q4 | $4.08M | Buy |
+125,000
| New | +$4.08M | 0.43% | 38 |
|